Molecular Characterization of Clinical Response and Relapse in Patients with IDH1m ND-AML Treated with Ivo+AZA in the AGILE Study
Year: 2022
Type: article
Source: Blood
Authors: Hartmut Döhner, Dylan M. Marchione, Sung Choe, Pau Montesinos, Christian Recher, Susana Vives, Ewa Zarzycka, Jianxiang Wang, Claudio Cerchione, Michael Heuser, Rodrigo T. Calado, Andre C. Schuh, Su-Peng Yeh, Adolfo De La Fuente, Jianan Hui, Prapti Patel, Diego A. Gianolio, Scott R. Daigle, Courtney D. DiNardo, Stephane De Botton
Institutions: University Hospital Ulm, Hospital Universitari i Politècnic La Fe, Instituto de Investigación Sanitaria La Fe, Centre Hospitalier Universitaire de Toulouse, Institut universitaire du cancer de Toulouse Oncopole, Gdańsk Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Medizinische Hochschule Hannover, Universidade de São Paulo, Princess Margaret Cancer Centre, China Medical University Hospital, MD Anderson Cancer Center Madrid, The University of Texas MD Anderson Cancer Center, Institut Gustave Roussy
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4310104190